Clinical Trials Logo
  1. Home
  2. Infant, Very Low Birth Weight
  3. NCT00601081
  4. Details
NCT00601081 Clinical Trial

Human Milk Fortifier and Cytokine Profile

Infant, Very Low Birth Weight Clinical Trial

Official title:
Alterations in the Cytokine Profile of Premature Infants After Human Milk Fortifier

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00601081
Other study ID # 27127
Secondary ID
Status Completed
Phase N/A
First received January 15, 2008
Last updated May 9, 2017
Start date November 2007
Est. completion date June 2008

Study information
Verified date May 2017
Source Christiana Care Health Services
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a research study investigating if adding human milk fortifier to a preterm babies breast milk feedings affects the baby's immune system.

Description:

In very low birth weight (VLBW) infants and preterm infants human milk fortifier (HMF) is often added to breast milk feedings in order to add extra calories, vitamins, and minerals. It is well known that breast milk feedings are easier to digest and have immune benefits compared to formula feedings. Cytokines, marker of immune function, can be found in blood, stool, and breast milk. This study involves collection of blood and stool samples to monitor cytokines. The purpose of this study is to understand whether human milk fortifier alters infants' cytokines.

Recruitment information / eligibility
Status Completed
Enrollment 24
Est. completion date June 2008
Est. primary completion date June 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 6 Months
Eligibility Inclusion Criteria:

- Infants born weighing less than 1500 grams

- exclusive breast milk feedings with intention to fortify with human milk fortifier

Exclusion Criteria:

- positive blood culture

- history of necrotizing enterocolitis

- significant lung disease at the start of the study

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
United States Christiana Hospital Newark Delaware

Sponsors (1)
Lead Sponsor Collaborator
Christiana Care Health Services

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Cytokine profile pre and post initiation of HMF up to 14 days
See also
  Status Clinical Trial Phase
Completed NCT02913677 - Prolonged Minimal Enteral Nutrition Versus Slowly Advancing Enteral Nutrition in Very Low Birth Weight Infants: N/A
Completed NCT02379728 - Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth N/A
Completed NCT01341236 - Near Infrared Spectroscopy (NIRS) and Superior Mesenteric Artery (SMA) Doppler Patterns as Predictor of Feeding Tolerance in Very Low Birth Weight (VLBW) IntraUterine Growth Restricted (IUGR) and NON IUGR Infants Phase 4
Completed NCT05217186 - Associations Between Early Neonatal Neuroimaging, Hammersmith Infant Neurological Examination and General Movements
Completed NCT03082313 - Movement-based Infant Intervention N/A
Terminated NCT01430832 - Developmental Outcomes of Extreme Prematurity, 5-15 Years Postpartum
Terminated NCT02599545 - Testosterone and Cortisol Levels in Infants
Completed NCT02583776 - Continuous Glucose Monitoring and Preterm Infants Phase 4
Active, not recruiting NCT01809548 - Preterm Infants on Early Solid Foods N/A
Completed NCT01363167 - Identifying Vitamin D Deficiency in Very Low Birth Weight Infant (VLBW) Infants Part 2 N/A
Completed NCT02078687 - Growth, Risks of Allergy and Metabolic Syndrome in 6 Year Old Children Born Preterm Compared to Postdischarge Nutrition N/A
Completed NCT01193270 - Vitamin E for Extremely Preterm Infants Phase 1
Completed NCT00760942 - Liquid Preterm Formula Versus Powdered Human Milk Fortifier in VLBW Infants N/A
Completed NCT02280031 - Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial. Phase 2
Completed NCT01717625 - The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia Phase 2
Completed NCT00009646 - Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP) Phase 3
Completed NCT00579943 - Regulation of Cerebral Blood Flow in Very Low Birth Weight Infants N/A
Completed NCT02389478 - Oropharyngeal Administration of Colostrum to Very Low Birth Weight Infants N/A
Recruiting NCT02016638 - Sleep Quality in Pregnancy and Its Impact on Pregnancy Outcomes N/A
Terminated NCT01799629 - Efficacy of Prophylactic Glycerin Suppositories for Feeding Intolerance in Very Low Birth Weight Preterm Infants: a Randomized Trial N/A